| Original language | English (US) |
|---|---|
| Pages (from-to) | 895-900 |
| Number of pages | 6 |
| Journal | Clinical breast cancer |
| Volume | 7 |
| Issue number | 11 |
| DOIs | |
| State | Published - Dec 2007 |
Keywords
- Aromatase inhibitors
- Estrogen receptor
- Selective estrogen receptor modulators
ASJC Scopus subject areas
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical breast cancer, Vol. 7, No. 11, 12.2007, p. 895-900.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - National Cancer Institute of Canada Clinical Trials Group MAR3 trial
T2 - Evaluation of exemestane to prevent breast cancer in postmenopausal women
AU - Goss, Paul E.
AU - Richardson, Harriet
AU - Chlebowski, Rowan
AU - Johnston, Dianne
AU - Sarto, Gloria E.
AU - Maunsell, Elizabeth
AU - Ingle, James N.
AU - Alés-Martinez, José E.
N1 - Funding Information: Editorial support was provided by Chris A. Kirk, PhD, of Complete Healthcare Communications, Inc, and was funded by Pfizer Inc. Paul E. Goss, MD, PhD, has served as a consultant/advisor for Pfizer, Astra Zeneca, and Novartis Oncology, and has received honoraria from Pfizer, Astra Zeneca, and Novartis Oncology. Harriet Richardson, PhD, has no conflict of interest to disclose. Rowan Cheblowski, MD, PhD, has served as a consultant for Astra Zeneca, Novartis Oncology, and Lilly, and has received grant support from Amgen and Lilly. Dianne Johnston has no conflict of interest to disclose. Gloria Sarto, MD, PhD, has no conflict of interest to disclose. Elizabeth Maunsell, PhD, has no financial relationships with commercial companies involved with a product under study in this trial. José E. Alés-Martinez, MD, PhD, has no conflict of interest to disclose. James N. Ingle, MD, has received honoraria for his services on an Advisory Committee and Speaker’s Bureau from Novartis Oncology.
PY - 2007/12
Y1 - 2007/12
KW - Aromatase inhibitors
KW - Estrogen receptor
KW - Selective estrogen receptor modulators
UR - http://www.scopus.com/inward/record.url?scp=38049037988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38049037988&partnerID=8YFLogxK
U2 - 10.3816/CBC.2007.n.057
DO - 10.3816/CBC.2007.n.057
M3 - Article
C2 - 18269782
AN - SCOPUS:38049037988
SN - 1526-8209
VL - 7
SP - 895
EP - 900
JO - Clinical breast cancer
JF - Clinical breast cancer
IS - 11
ER -